Patient-Centered NeuroRehabilitation (PCN)
Launched by UNIVERSITY OF MICHIGAN · Jan 25, 2017
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Patient-Centered NeuroRehabilitation (PCN) trial is studying ways to improve thinking skills in older adults who may have cognitive difficulties. As we age, our ability to think clearly can decline due to various reasons, including normal aging and certain health conditions. This study will look at two methods: cognitive rehabilitation, which helps people improve everyday tasks they struggle with, and transcranial electrical stimulation (TES), a technique that uses safe, small amounts of electricity to potentially boost brain function. The goal is to find out how these methods can help improve skills such as attention, memory, and problem-solving.
To participate in this study, individuals must be 50 years or older and can either have reported cognitive challenges or be cognitively healthy. However, those with serious mental health issues, certain physical impairments, or a history of substance abuse cannot take part. Participants can expect to engage in activities designed to enhance their cognitive abilities, and all procedures will be explained clearly. It's important to note that individuals with certain medical implants affecting the TES method will also be excluded from the study. This trial is currently recruiting participants, and if you think you might be eligible, it could be a chance to contribute to important research in cognitive health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Individuals who have reported cognitive dysfunction and cognitively intact participants.
- • 2. Participants will be age 50 or older
- Exclusion Criteria:
- • 1. A history of epilepsy
- • 2. Sensory or motor impairments that limit the ability to take part in the study
- • 3. Current alcohol or drug abuse/dependence
- • 4. Those who are currently pregnant or may become pregnant during the duration of the study (if there is a question of pregnancy, pregnancy tests will be available for participants at no charge)
- • Those who are being evaluated for TES methodology will also be excluded for 1) metallic or electronic implant 2) skull plates or other cranial implants that affect TES
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Benjamin M Hampstead, Ph.D.
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials